Search research articles
Contact Us
Filters
Showing results (81-90 of 90) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 90 results.
Inflammopharmacology
|
January 1, 1997
Ankylosing spondylitis antirheumatic drug trials: Effects of a standardized instructional viddeotape on the reliability of observer-dependent outcome measures
N Bellamy, K D Muirden, K Boyden, et al.
The Medical Journal of Australia
|
December 7, 1992
Non-steroidal anti-inflammatory drug induced upper gastrointestinal haemorrhage and bleeding
R O Day, D A Henry, K D Muirden, et al.
Rheumatology International
|
September 10, 2005
Clinical, laboratory and genetic markers associated with erosions and remission in patients with early inflammatory arthritis: a prospective cohort study
A Stockman, B D Tait, R Wolfe, et al.
Inflammopharmacology
|
January 1, 1997
Rheumatoid arthritis antirheumatic drug trials: effects of a standardized instructional videotape on the reliability of observer-dependent outcome measures
N Bellamy, K D Muirden, A Bendrups, et al.
Arthritis and Rheumatism
|
January 1, 2000
Antibodies to type II collagen and HLA disease susceptibility markers in rheumatoid arthritis
A D Cook, A Stockman, C A Brand, et al.
Arthritis and Rheumatism
|
November 1, 1987
A comparison of changes seen on radiographs of rheumatoid arthritis patients in Australia and in China
H Moran, S L Chen, K D Muirden, et al.
Annals of the Rheumatic Diseases
|
July 1, 1986
A comparison of rheumatoid arthritis in Australia and China
H Moran, S L Chen, K D Muirden, et al.
The Journal of Rheumatology
|
April 1, 1986
Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine
A Stockman, P J Zilko, G A Major, et al.
The Journal of Rheumatology. Supplement
|
September 1, 1994
World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials
M Boers, P Tugwell, D T Felson, et al.
Scandinavian Journal of Rheumatology
|
January 1, 1997
The effect of HLA-DRB1 disease susceptibility markers on the expression of RA
M J Rowley, A Stockman, C A Brand, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 90) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 90 results.
Inflammopharmacology
|
January 1, 1997
Ankylosing spondylitis antirheumatic drug trials: Effects of a standardized instructional viddeotape on the reliability of observer-dependent outcome measures
N Bellamy, K D Muirden, K Boyden, et al.
The Medical Journal of Australia
|
December 7, 1992
Non-steroidal anti-inflammatory drug induced upper gastrointestinal haemorrhage and bleeding
R O Day, D A Henry, K D Muirden, et al.
Rheumatology International
|
September 10, 2005
Clinical, laboratory and genetic markers associated with erosions and remission in patients with early inflammatory arthritis: a prospective cohort study
A Stockman, B D Tait, R Wolfe, et al.
Inflammopharmacology
|
January 1, 1997
Rheumatoid arthritis antirheumatic drug trials: effects of a standardized instructional videotape on the reliability of observer-dependent outcome measures
N Bellamy, K D Muirden, A Bendrups, et al.
Arthritis and Rheumatism
|
January 1, 2000
Antibodies to type II collagen and HLA disease susceptibility markers in rheumatoid arthritis
A D Cook, A Stockman, C A Brand, et al.
Arthritis and Rheumatism
|
November 1, 1987
A comparison of changes seen on radiographs of rheumatoid arthritis patients in Australia and in China
H Moran, S L Chen, K D Muirden, et al.
Annals of the Rheumatic Diseases
|
July 1, 1986
A comparison of rheumatoid arthritis in Australia and China
H Moran, S L Chen, K D Muirden, et al.
The Journal of Rheumatology
|
April 1, 1986
Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine
A Stockman, P J Zilko, G A Major, et al.
The Journal of Rheumatology. Supplement
|
September 1, 1994
World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials
M Boers, P Tugwell, D T Felson, et al.
Scandinavian Journal of Rheumatology
|
January 1, 1997
The effect of HLA-DRB1 disease susceptibility markers on the expression of RA
M J Rowley, A Stockman, C A Brand, et al.
Page
of 9